ProtoKinetix Targets Multi Billion Dollar Stem Cell Industry
News Aug 16, 2007
This emerging industry generated $12 Billion in revenues in 2005 and is forecasted to exceed $50 Billion in 2010. In this recent report, AAGP™ was shown to produce significant increases in stem cell viability and competence under both cryopreservation (-80°C) and at refrigeration (+4°C) temperatures.
This analysis consolidates data from previous findings and observed no conflicting observations. Using cryopreservation on a range of both mouse and human embryonic stem cell lines, there was a consistent increase in the viable yield of almost 100% (from 40% to 76%). Other tests show that 96% of the cells remain in an unaffected state indicating that the stem cells are still competent.
These findings show that AAGP™ not only increases cell viability but also maintains cell competence for future use in therapies.
This report and other research data are to be presented to the commercial stem cell storage industry.
Scientists at the University of Bristol have invented a new technology that could lead to the development of a new generation of smart surgical glues and dressings for chronic wounds. The new method involves re-engineering the membranes of stem cells to effectively “weld” the cells together.READ MORE
Zebrafish, in contrast to humans, have outstanding regenerative capacities: and can regrow brain cells from so-called progenitor cells. Scientists have now determined that these progenitor cells consist of eight different sub-populations. In a fish model of Alzheimer’s disease, only some of these populations increased proliferation to restore lost cells.READ MORE